Elin Lindhagen

Papers

Total Citations

236

H-Index

About

Elin Lindhagen is a prominent figure in cancer pharmacology, best known for pioneering advances in drug sensitivity testing and cellular cytotoxicity assays. Her foundational work, "The fluorometric microculture cytotoxicity assay" (2008), has garnered 236 citations and remains a cornerstone methodology for evaluating anticancer drug effects in vitro. Lindhagen’s research primarily focuses on developing and refining high-throughput, fluorometric techniques to measure cell viability and apoptosis, enabling more accurate and reproducible assessments of chemotherapeutic agents. Her contributions have significantly improved preclinical drug screening, allowing researchers to predict patient-specific responses to treatment. Beyond this landmark paper, Lindhagen has explored mechanisms of drug resistance and the optimization of combination therapies, influencing both basic cancer biology and translational oncology. Her methodological innovations have been widely adopted in laboratories worldwide, underscoring her impact on the field. For students and researchers, Lindhagen’s work exemplifies how robust assay development can drive meaningful progress in personalized medicine and cancer therapeutics.